Prospective observational registry for cystinuria patients on Thiola EC therapy

Go Back to All Clinical Trials

Prospective observational registry for cystinuria patients on Thiola EC therapy

Brief description of study

In this phase 4 study we will observe the tolerance and effect of Thiola EC in patients with cystinuria. The drug will be administered three times a day to people who are currently taking tiopronin, or for new patients who require tiopronin, as determined by their treating physician, in order to address continued cystine stone formation.

Clinical Study Identifier: s20-00331

ClinicalTrials.gov Identifier: NCT05048563

Principal Investigator: David S. Goldfarb.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies